Long-acting, reversible and permanent methods of contraception' insight into women's choice of method

Quality in Primary Care

Volumn 17, Issue 2, 2009, Pages 107-114

  Kane, Roslyn ^a   Irving, Gwen ^b,c   Brown, Sally ^c,d   Parkes, Neal ^e   Walling, Martin ^e   Killick, Stephen ^c  

^a UNIVERSITY OF LINCOLN   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

^e Lincolnshire Primary Care Trust   (United Kingdom)

Author keywords

Contraception; Long acting reversible (LARC) methods; Sterilisation

Indexed keywords

ETONOGESTREL; LEVONORGESTREL; PROGESTERONE;

ABDOMINAL PAIN; ACNE; ADULT; AMENORRHEA; ARTICLE; BLOATING; BREAST TENDERNESS; CONTRACEPTION; DECISION MAKING; DEPRESSION; DRUG INDUCED HEADACHE; FAMILY PLANNING; FATIGUE; FEMALE; FEMALE STERILIZATION; HAIR GROWTH; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; LIBIDO DISORDER; MENSTRUATION DISORDER; MOOD DISORDER; NAUSEA; PAIN; PELVIS PAIN SYNDROME; PRURITUS; SIDE EFFECT; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINITIS; WEIGHT GAIN; WOMEN'S HEALTH;

ADULT; CHOICE BEHAVIOR; CONTRACEPTION; CONTRACEPTION BEHAVIOR; DESOGESTREL; DRUG IMPLANTS; EMOTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; INTRAUTERINE DEVICES; MIDDLE AGED; PREGNANCY, UNPLANNED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 65649095240     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Taylor T, Keyse L and Bryant A. Office for National Statistics. Social Survey Division, ONS Omnibus Survey, Contraception and Sexual Health 2005/06. Omnibus Report Number 30. London: Office for National Statistics, 2006.
2. Oddens B. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999;59:277-86.
3. Peterson H, Xia Z, Hughes J et al. The risk of pregnancy after tubal sterilization: findings from the US Collaborative Review of Sterilization. ACOG Clinical Review 1996; 1(5):6-6.
4. Chapron C, Pierre F, Querleu-D and Dubuisson JB. [Complications of laparoscopy in gynecology.] Gynécologie Obstétrique & Fertilité 2001;29:605-12.
5. Hillis SD, Marchbanks PA, Tylor LR and Peterson HB. Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstetrics and Gynecology 1999;93:889-95.
6. Wilcox LS, Chu SY, Eaker ED, Zeger SL and Peterson HB. Risk factors for regret after tubal sterilization: 5 years of follow-up in a prospective study. Fertility and Sterility 1991;55:927-33.
7. Schmidt JE, Hillis SD, Marchbanks PA, Jeng G and Peterson HB. Requesting information about and obtaining reversal after tubal sterilization: findings from the US Collaborative Review of Sterilization. Fertility and Sterility 2000;74:892-8.
8. Curtis KM, Mohllajee AP and Peterson HB. Regret following female sterilization at a young age: a systematic review. Contraception 2006;73:205-10.
9. Grubb GS, Peterson HB, Layde PM and Rubin GL. Regret after decision to have a tubal sterilization. Fertility and Sterility 1985; 44:248-53.
10. Jamieson DJ, Kaufman SC, Costello C et al, US Collaborative Review of Sterilization Working Group. A comparison of women's regret after vasectomy versus tubal sterilization. Obstetrics and Gynecology 2002;99: 1073-9.
11. Miller WB, Shain RN and Pasta DJ. The pre- and poststerilization predictors of poststerilization regret in husbands and wives, Journal of Nervous and Mental Disease 1991;179:602-8.
12. Thranov I, Kjersgaard AG, Rasmussen OV and Hertz J. Regret among 547 Danish sterilized women. Scandinavian Journal of Social Medicine 1988;16:41-8.
13. National Institute for Health and Clinical Excellence. Long-acting Reversible Contraception. The effective and appropriate use of long-acting reversible contraception. National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Health and Clinical Excellence. London: RCOG Press, 2005.
14. Faculty of Family Planning and Reproductive Healthcare of the Royal Society of Obstetricians and Gynaecologists. FFPRHC Guidance. The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health. Journal of Family Planning and Reproductive Health Care 2004;30:99-109.
15. French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. British Journal of Obstetrics and Gynaecology 2000; 107:1218-25.
16. French R, Van Vliet H, Cowan F et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. The Cochrane Library, Issue 3. Oxford: Update Software, 2004, CD001776.
17. Javela I, Tekay A and Jouppila P. The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women. Human Reproduction 1998;13:3379-83.
18. Abdel Malak K and Shawki O. Management of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Gynecological Surgery 2006;3: 275-80.
19. Busfield RA, Farquhar CM, Sowter MC et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG: An International Journal of Obstetrics and Gynaecology 2006;113:257-63.
20. Dolan LM, Mulholland M and Price J. The levonorgestrel intra-uterine system: therapeutic application in family planning. Journal of Family Planning and Reproductive Health Care 2001;27:19-21.
21. Schering Health Care Ltd. Mirena. 0053/0265,1-8, 2002. www.schering.co.uk (accessed 2 February 2009).
22. Flores JB, Balderas ML, Bonilla MC and Vázquez-Estrada L. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant. International Journal of Gynaecology and Obstetrics 2005;90: 228-33.
23. Funk S, Miller MM, Mishell DR Jr et al, The Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319-26.
24. Glasier A. Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility and outcome of pregnancies. Contraception 2002;65:29-37.
25. Phillips CJ. Economic analysis of long-term reversible contraceptives. Focus on Implanon. Pharmacoeconomics 2000;17:209-21.
26. Lakha F and Glasier AF. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception 2006;74:287-9.
27. Kiriwat O, Patanayindee A, Koetsawang S, Korver T and Bennink HJ. A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand. European Journal of Contraception and Reproductive Health Care 1998;3:85-91.
28. Varney SJ and Guest JF. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. Pharmaco-economics 2004;22:1141-51.
29. Power J, French R and Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. The Cochrane Library, Issue 3. Oxford: Update Software, 2004, CD001326.
30. Darney PD. Implantable contraception. European Journal of Contraception and Reproductive Health Care 2000;5(suppl 2):2-11.
31. Rai K, Gupta S and Cotter S. Experience with ETN implant in a northeast London family planning clinic. European Journal of Contraception and Reproductive Health Care 2004;9:39-46.
32. Singh M, Mansour D and Richardson D. Location and removal of non-palpable Implanon® implants with the aid of ultrasound guidance. Journal of Family Planning and Reproductive Health Care 2006; 32:153-6.
33. Harrison-Woolrych M and Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005;71:306-8.
34. Mansour M, Louis-Sylvestre C and Paniel BJ [Ectopic pregnancy with etonogestrel contraceptive implant (Implanon): first case.] Journal de Gynécologie, Obstétrique et Biologie de al Reproduction (Paris) 2005;34:608-9.
35. Smith A and Reuter S. An assessment of the use of Implanon in three community services. Journal of Family Planning and Reproductive Health Care 2002; 28:193-6.
36. Bowling A. Research Methods in Health. Investigating health and health sciences (2e). Maidenhead: Open University Press, 2002.
37. Ritchie J and Spencer L. Qualitative data analysis for applied policy research. In: Bryman A and Burgess R (eds) Analysing Qualitative Data. London: Routledge, 1994.
38. Office for National Statistics (ONS). Marriage and Divorce Rates: EU comparison, 2002. Social Trends 34 January 2004. www.statistics.gov.uk/STATBASE/ssdataset.asp?vlnk=7265 (accessed 2 February 2009).